The case of development of HIV-associated Kaposi's sarcoma with skin and lung lesions
- Authors: Kobernik M.Y.1, Nikolenko V.V.1, Mikova O.E.2, Zavyalova A.A.1, Pyankova M.A.1
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Perm Regional Center for the Prevention and Control of AIDS and Infectious Diseases
- Issue: Vol 41, No 3 (2024)
- Pages: 153-159
- Section: Clinical case
- URL: https://journals.rcsi.science/PMJ/article/view/260597
- DOI: https://doi.org/10.17816/pmj413153-159
- ID: 260597
Cite item
Full Text
Abstract
A clinical case of HIV-associated Kaposi's sarcoma with skin and lung lesions is presented. A patient referred to the Perm Regional Center for the Prevention and Control of AIDS and Infectious Diseases complaining of rash on the skin of the right wing of the nose, forehead, in the right axillary and right inguinal areas, on the shins. The first skin changes occurred in December 2020 on the right wing of the nose, later the pathological process spread to other areas of the skin. HIV was revealed in 2009 and the patient had not received specialized medical care until 2022 as he had been in prison. Since March 2022, the patient has been registered at the dispensary and regularly receives antiretroviral therapy. In April 2022, PET/CT tests and histological examination of a biopsy of skin rashes were performed. On the basis of these findings the diagnosis of Kaposi's sarcoma with skin and lungs lesions was made.
HIV-associated Kaposi's sarcoma is accompanied by lesions of the skin and internal organs. Skin changes in Kaposi's sarcoma are characterized by the primary localization of foci on the face and upper extremities, and without antiretroviral therapy, by rapid progression and generalization of the pathological process. Visceral lesions worsen the course of the disease and complicate its prognosis. Patients with HIV-associated Kaposi's sarcoma need dynamic monitoring and complex therapy from infectious diseases specialists, dermatovenerologists, oncologists.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
M. Yu. Kobernik
E.A. Vagner Perm State Medical University
Author for correspondence.
Email: margo110875@yandex.ru
ORCID iD: 0000-0002-3549-0076
PhD (Medicine), Associate Professor of the Department of Dermatovenerology
Russian Federation, PermV. V. Nikolenko
E.A. Vagner Perm State Medical University
Email: margo110875@yandex.ru
ORCID iD: 0000-0002-9505-1569
DSc (Medicine), Professor of the Department of Infectious Diseases
Russian Federation, PermO. E. Mikova
Perm Regional Center for the Prevention and Control of AIDS and Infectious Diseases
Email: margo110875@yandex.ru
PhD (Medicine), Deputy Chief Medical Officer
Russian Federation, PermA. A. Zavyalova
E.A. Vagner Perm State Medical University
Email: margo110875@yandex.ru
5th-year student of the Medical Faculty
Russian Federation, PermM. A. Pyankova
E.A. Vagner Perm State Medical University
Email: margo110875@yandex.ru
5th-year student of the Medical Faculty
Russian Federation, PermReferences
- ВИЧ-инфекция и СПИД: национальное руководство. 2-е изд. Под ред. В.В. Покровского. М.: ГЭОТАР-Медиа 2020; 686 / HIV infection and AIDS: national guidelines: 2nd edition. Ed. V.V. Pokrovsky. M.: GEOTAR-Media, 2020; 686 (in Russian).
- Николенко В.В., Николенко А.В., Миникеева М.Р. Изучение изменений нутритивного статуса у ВИЧ-позитивных пациентов с пневмониями, вызванными Streptococcus рneumoniaе. Пермский медицинский журнал. 2018; 4: 14–19. doi: 10.17816/pmj35414-19 / Nikolenko V.V., Nikolenko A.V., Minikeyeva M.R. Study of changes in nutritional status in HIV-positive patients with pneumonia caused by Streptococcus pneumoniae. Perm Medical Journal 2018; 4: 14–19. doi: 10.17816/pmj35414-19 (in Russian).
- Кошкин С.В., Евсеева А.П., Рябова В.В., Коврова О.С. Особенности течения сифилиса у ВИЧ-инфицированных пациентов: клинический случай. Вестник дерматологии и венерологии. 2020; 96 (1): 52–57. doi: 10.25208/vdv553-2020-96-1-52-57 / Koshkin S.V., Evseeva A.P., Ryabova V.V., Kovrova O.S. Features of the course of syphilis in HIV-infected patients: a clinical case. Bulletin of Dermatology and Venereology. 2020; 96 (1): 52–57. doi: 10.25208/vdv553-2020-96-1-52-57 (in Russian).
- Cesarman E., Damania B., Krown S.E. Kaposi Sarcoma. Nat. Rev. Dis. Primers. 2019; 5 (1): 9. doi: 10.1038/s41572-019-0060-9.
- Debordes P.A., Hamoudi C., Di Marco A. Metastatic Kaposi sarcoma in a non-HIV patient leading to metacarpal lysis then upper-limb amputation: a case report. Case Reports. Plast. Surg. Hand. Surg. 2023; 10 (1): 2251581. doi: 10.1080/23320885.2023.2251581.
- Openshaw M.R., Gervasi E., Fulgenzi C.A., Pinato D.J., Dalla Pria A., Bower M. Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immuno-pathogenesis. J. Transl. Med. 2023; 21 (1): 283. doi: 10.1186/s12967-023-04130-6.
- Shiels M.S., Engels E.A. Evolving epidemiology of HIV-associated malignancies. Curr. Opin. HIV AIDS. 2017; 12 (1): 6–11. doi: 10.1097/COH.0000000000000327.
- Елькин В.Д., Коберник М.Ю., Микова О.Е. СПИД-индикаторный дерматологический синдром у ВИЧ-инфицированного пациента. Пермский медицинский журнал 2022; 32 (1): 131–134 / El`kin V.D., Kobernik M.Yu., Mikova O.E. AIDS is an indicator dermatological syndrome in an HIV-infected patient. Perm Medical Journal 2022; 32 (1): 131–134 (in Russian).
- Кошкин С.В., Евсеева А.П., Рябова В.В., Коврова О.С. Клиническое наблюдение вторичного сифилиса у ВИЧ-инфицированного пациента. РМЖ. Медицинское обозрение. 2021; 5 (11): 778–781. doi: 10.32364/2587-6821-2021-5-11-778-781 / Koshkin S.V., Ev¬seeva A.P., Ryabova V.V., Kovrova O.S. Clinical observation of secondary syphilis in an HIV-infected patient. Rus-sian Medical Inquiry 2021; 5 (11): 778–781. doi: 10.32364/2587-6821-2021-5-11-778-781 (in Russian).
- Vangipuram R., Tyring S.K. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int. J. Dermatol. 2019; 58 (5): 538–542. doi: 10.1111/ijd.14080.
- Tekcan Sanli D.E., Kiziltas S. Gastrointestinal Kaposi's Sarcoma. N. Engl. J. Med. 2023; 388 (13): e45. doi: 10.1056/NEJMicm2102502.
- Vally F., Selvaraj W., Ngalamika O. Ad-mitted AIDS-associated Kaposi sarcoma patients. Indications for admission and predictors of mortality. Medicine (Baltimore). 2020; 99 (39): e22415. doi: 10.1097/MD.0000000000022415.
- Nwabudike S.M., Hemmings S., Paul Y. Pulmonary Kaposi Sarcoma: an uncommon cause of respiratory failure in the era of highly active antiretroviral therapy – case report and review of the literature. Case Rep. Infect. Dis. 2016; 2016: 9354136. doi: 10.1155/2016/9354136.
- Radu O., Pantanowitz L. Kaposi sarcoma. Arch. Pathol. Lab. Med. 2013; 137 (2): 289–294. doi: 10.5858/arpa.2012-0101-RS.
- Dupin N. Update on oncogenesis and therapy for Kaposi sarcoma. Curr. Opin. Oncol. 2020; 32 (2): 122–128. doi: 10.1097/CCO.0000000000000601.